Advertisement

HIV

A 17-year-old Canadian has earned first place at Intel's 2015 International Science and Engineering Fair, which the company claims is the biggest high school science competition in the world. Raymond Wang's system to improve air quality in airplane cabins scooped the US$75,000 top prize ahead of a low-cost HIV testing device and a new containment enclosure for undersea oil wells.

Read More
A novel vaccine for the AIDS virus may become possible through a new compound proving highly effective in preventing HIV infection. While testing has only been carried out on monkeys so far, the scientists behind the development say that with its ability to block multiple strains of infection at once, the technique has huge potential to one day provide long-lasting protection against the deadly virus. Read More
Researchers at the University of Washington (UW) have developed a material that could offer women a new means of protection against HIV. Demonstrated in the form of a tampon, the material is capable of carrying substantial loads of medicine, dissolving and releasing the drugs once its comes into contact with moisture. Read More
Medicine Patent Pool (MPP), a not-for-profit organization, has partnered with pharmaceutical company Gilead Sciences to produce a generic version of a new HIV treatment drug in India and China that will be distributed in 112 countries. Read More
Researchers from Temple University School of Medicine have discovered how to permanently extricate HIV-1 from human cells, possibly avoiding the need for lifelong drug treatment. Though in its very early stages, this may prove to be a critical step in permanently defeating the disease. Read More
A very promising vaccine candidate for HIV/AIDS has shown the ability to completely clear the simian immunodeficiency virus (SIV), a very aggressive form of HIV that leads to AIDS in monkeys. Developed at the Vaccine and Gene Therapy Institute at the Oregon Health and Science University (OHSU), the vaccine proved successful in about fifty percent of the subjects tested and could lead to a human vaccine preventing the onset of HIV/AIDS and even cure patients currently on anti-retroviral drugs. Read More
One of the biggest problems in treating HIV patients is the amount of daily individual medications it takes to keep the virus at bay. In a new study, scientists at the Stanford University School of Medicine have engineered a new approach to tailored gene therapy that they say makes key cells of the immune system resistant to attack from the HIV virus, which may eventually lead to the removal of life-long dependencies on drugs for patients living with HIV. Read More

Scientists at The Rockefeller University have found that harnessing proteins from the human immune system can suppress the HIV virus in mice. Potentially, this could lead to a therapeutic approach to treating the virus that does not require a daily application of drugs. Read More

Advertisement